Effect of Proton-Pump Inhibitor on Survival in Chinese Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Receiving Upfront Combinatorial Docetaxel Treatment
Prostate cancer is the second most commonly found malignancy for men worldwide, with its prevalence increasing with age [...].
Authors
- Cheuk Y. Tang (ORCID: https://orcid.org/0000-0002-9828-0092)
- Chris Ho Ming Wong (ORCID: https://orcid.org/0000-0003-1795-1198)
- Joanne Chiu
- Chi‐Ho Leung (ORCID: https://orcid.org/0000-0001-5484-9390)
- Peter Ka‐Fung Chiu (ORCID: https://orcid.org/0000-0002-1499-8372)
- H. Mok
- Yu Jin Lim (ORCID: https://orcid.org/0000-0003-2243-8989)
- Jeremy Yuen‐Chun Teoh (ORCID: https://orcid.org/0000-0002-9361-2342)
- Chi‐Fai Ng (ORCID: https://orcid.org/0000-0002-1723-9646)
- David Leung (ORCID: https://orcid.org/0000-0002-2078-7934)
- Kang Liu (ORCID: https://orcid.org/0000-0001-7929-6534)
- Ivan Ching‐Ho Ko (ORCID: https://orcid.org/0000-0003-1682-1420)
- Carol Kwok (ORCID: https://orcid.org/0009-0000-0041-3532)
- Brian Siu (ORCID: https://orcid.org/0009-0000-7974-6371)
- C. Cheng (ORCID: https://orcid.org/0000-0002-3294-8790)
Institutions
- Chinese University of Hong Kong (HK)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3390/cancers17172879
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00